Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis

  Free Subscription


Articles published in Drugs

Retrieve available abstracts of 9 articles:
HTML format



Single Articles


    January 2021
  1. SEPULVEDA-CRESPO D, Resino S, Martinez I
    Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.
    Drugs. 2021 Jan 5. pii: 10.1007/s40265-020-01458.
    PubMed     Abstract available


    June 2019
  2. MANKA P, Zeller A, Syn WK
    Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities.
    Drugs. 2019;79:903-927.
    PubMed     Abstract available


    August 2018
  3. MARKHAM A, Keam SJ
    Danoprevir: First Global Approval.
    Drugs. 2018 Aug 16. pii: 10.1007/s40265-018-0960.
    PubMed     Abstract available


    March 2018
  4. HEO YA, Deeks ED
    Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C.
    Drugs. 2018 Mar 15. pii: 10.1007/s40265-018-0895.
    PubMed     Abstract available


    January 2018
  5. SCOTT LJ
    Ledipasvir/Sofosbuvir: A Review in Chronic Hepatitis C.
    Drugs. 2018 Jan 29. pii: 10.1007/s40265-018-0864.
    PubMed     Abstract available


    June 2017
  6. DAWOOD A, Abdul Basit S, Jayaraj M, Gish RG, et al
    Drugs in Development for Hepatitis B.
    Drugs. 2017 Jun 28. doi: 10.1007/s40265-017-0769.
    PubMed     Abstract available


    May 2017
  7. BAGAGLIO S, Uberti-Foppa C, Morsica G
    Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.
    Drugs. 2017 May 12. doi: 10.1007/s40265-017-0753.
    PubMed     Abstract available


  8. SCOTT LJ, Chan HLY
    Tenofovir Alafenamide: A Review in Chronic Hepatitis B.
    Drugs. 2017 May 11. doi: 10.1007/s40265-017-0754.
    PubMed     Abstract available


    April 2017
  9. AL-SALAMA ZT, Deeks ED
    Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4.
    Drugs. 2017 Apr 17. doi: 10.1007/s40265-017-0739.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: